ANTHRACYCLINE-INDUCED CARDIOTOXICITY
Clinical trials for ANTHRACYCLINE-INDUCED CARDIOTOXICITY explained in plain language.
Never miss a new study
Get alerted when new ANTHRACYCLINE-INDUCED CARDIOTOXICITY trials appear
Sign up with your email to follow new studies for ANTHRACYCLINE-INDUCED CARDIOTOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New trial aims to shield hearts from chemo side effects
Prevention Not yet recruitingThis study tests whether a drug called sotagliflozin can prevent heart, muscle, and fat damage caused by a common type of chemotherapy (anthracycline) in people with newly diagnosed lymphoma. About 60 adults who are scheduled to receive high-dose anthracycline will take either th…
Matched conditions: ANTHRACYCLINE-INDUCED CARDIOTOXICITY
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC
-
Heart shield: statin may guard against chemo damage in breast cancer
Prevention Not yet recruitingThis study tests whether taking rosuvastatin, a cholesterol-lowering drug, can prevent heart damage caused by anthracycline chemotherapy in women with breast cancer. Four hundred participants will receive either rosuvastatin or a placebo daily for 12 months. The main goal is to s…
Matched conditions: ANTHRACYCLINE-INDUCED CARDIOTOXICITY
Phase: PHASE4 • Sponsor: Shiraz University of Medical Sciences • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC